Compare Nuwellis Inc (NUWE) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while ZIM Integrated Shipping Services Ltd trades at $30.07 (market cap $3.65B). The key difference: ZIM Integrated Shipping Services Ltd is far larger — about 1659.1× Nuwellis Inc's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| NUWE | ZIM | |
|---|---|---|
Market Cap | $2.20M | $3.65B |
Volume | 121,544 | 1,068,475 |
Sector | Health | Industrials |
52-Week High | $146.65 | $30.51 |
52-Week Low | $0.68 | $12.44 |
Typical Hold Time | 26 Days | 27 Days |
Enterprise Value | -$1.52M | $7.32B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
ZIM Integrated Shipping Services trades at $30.31, up 1.07% with a bullish technical signal from moving averages. The stock shows mixed fundamentals with declining revenue from $6.9B in 2025 to $6.4B in 2026 and net income dropping from $479M to $139M, though Q2 2026 earnings beat expectations. Recent news highlights a potential $35 per share acquisition offer from Hapag-Lloyd pending Israeli government approval, creating significant uncertainty.
The investment outlook balances acquisition upside against operational challenges. While valuation metrics appear reasonable (P/E 26.31, P/S 0.57), declining profitability and the uncertain merger outcome present substantial risk. Analyst sentiment remains cautious with no buy ratings, reflecting concerns about the company's standalone prospects if the acquisition fails to materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
